Medicinal cannabis in Australia is not available for general retail purchase and is accessed through regulated medical pathways.
A prescription from a registered medical practitioner is required, and all prescribing is subject to national oversight.
To understand how access works in Australia, it is helpful to review how these pathways are structured.
Access to medicinal cannabis is managed through established frameworks, including:
Special Access Scheme (SAS)
Authorised Prescriber pathways
These pathways ensure that decisions are made based on individual clinical assessment.
Patients often explore medicinal cannabis access pathways in Australia to understand how access is managed.
A qualified practitioner will assess:
medical history
current treatments
overall health considerations
Not all individuals will be considered suitable for this approach.
This process forms part of a structured consultation process used to guide clinical decisions.
Consultations may be conducted via telehealth, allowing patients across Australia to connect with practitioners regardless of location.
This supports a consistent and regulated consultation pathway.
Medicinal cannabis is not suitable for all patients and must be prescribed by a qualified practitioner.
Learning about consultation pathways can help explain how regulated access operates in Australia.